These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of auranofin and aurothioglucose in the treatment of rheumatoid arthritis: a single blind study. van Riel PL; van de Putte LB; Gribnau FW; Macrae KD Clin Rheumatol; 1984 Mar; 3 Suppl 1():51-6. PubMed ID: 6432414 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of lymphocyte subpopulations using monoclonal antibodies in patients with rheumatoid arthritis undergoing treatment with a new gold salt (auranofin)]. Di Matteo L; D'Incecco V; Evangelista L; Castiglione C; Consoli G Boll Soc Ital Biol Sper; 1985 May; 61(5):777-81. PubMed ID: 3927943 [No Abstract] [Full Text] [Related]
9. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts]. Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604 [No Abstract] [Full Text] [Related]
10. Bronchiolitis in a rheumatoid arthritis patient receiving auranofin. O'Duffy JD; Luthra HS; Unni KK; Hyatt RE Arthritis Rheum; 1986 Apr; 29(4):556-9. PubMed ID: 3085683 [TBL] [Abstract][Full Text] [Related]
11. Effects of gold compounds on function of phagocytic cells. Comparative inhibition of activated polymorphonuclear leukocytes and monocytes from rheumatoid arthritis and control subjects. Davis P; Johnston C Inflammation; 1986 Sep; 10(3):311-20. PubMed ID: 3017859 [TBL] [Abstract][Full Text] [Related]
12. [Basic therapy of rheumatoid arthritis with auranofin]. Goebel KM Dtsch Med Wochenschr; 1985 Jan; 110(2):64-5. PubMed ID: 3917898 [No Abstract] [Full Text] [Related]
13. The efficacy of parenteral gold after auranofin failure in rheumatoid arthritis. Wessel J; Davis P J Rheumatol; 1983 Aug; 10(4):664. PubMed ID: 6413690 [No Abstract] [Full Text] [Related]
14. Auranofin in the treatment of rheumatoid arthritis. A two-year study. Baldassare AR; Weiss TD; Arthur RE; Osborn TG; Moore TL; Zuckner J Mo Med; 1985 Nov; 82(11):711-5. PubMed ID: 3934512 [No Abstract] [Full Text] [Related]
15. Auranofin: more than just oral gold. Waller ES Clin Pharm; 1984; 3(2):195. PubMed ID: 6426845 [No Abstract] [Full Text] [Related]
16. [Auranofin]. Ferrari M; Piro MT Recenti Prog Med; 1983 Aug; 74(8):968-70. PubMed ID: 6417742 [No Abstract] [Full Text] [Related]
17. Changes in mononuclear cell function in patients with rheumatoid arthritis following treatment with auranofin. Coughlan RJ; Richter MB; Panayi GS Clin Rheumatol; 1984 Mar; 3 Suppl 1():25-32. PubMed ID: 6432410 [TBL] [Abstract][Full Text] [Related]
18. Treatment with auranofin in patients with rheumatoid arthritis, previously experiencing drug related side effects to sodium aurothiomalate. Davis P; Landon M J Rheumatol; 1985 Jun; 12(3):622. PubMed ID: 3930724 [No Abstract] [Full Text] [Related]
19. The effect of piroxicam and auranofin on cell migration. Rueda HA; Scheinberg MA Clin Rheumatol; 1985 Mar; 4(1):68-72. PubMed ID: 3921306 [TBL] [Abstract][Full Text] [Related]
20. II. Unbound versus total serum gold concentration: pharmacological actions on cellular function. Lorber A; Kunishima DH; Harralson AF; Simon TM J Rheumatol; 1983 Aug; 10(4):568-73. PubMed ID: 6413684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]